Ep1: Transatlantic Investing and Fund II Strategy, with Panakes Partners
Episode 1: Panakes
Title: Transatlantic Investing and Fund II Strategy, with Panakes Partners
What’s shaping the future of Life Sciences? Join Henry Peck as he chats with Diana Saraceni and Alessio Beverina, co-founders and managing directors of Panakes, a venture capital firm that’s helping to build the next generation of game-changing technologies companies in the field of Life Sciences.
Diana brings 23 years of venture capital experience and previously co-founded another successful venture capital firm called 360 Capital. Alessio, with an engineering background, co-founded Panakes in 2015 after working as a research engineer at Sofinnova Partners.
Throughout the episode, Diana and Alessio provide valuable insights into the evolving landscape of medtech investing, shedding light on the complexities, challenges, and opportunities in the field.
Topics include:
- Current market conditions and challenges faced by companies in medtech
- Key learnings from Panakes’ first fund which focused on medtech and raised €75 million
- Strategies for the newly raised second fund, with plans to expand its focus to include biotech and opportunities where medtech and biotech converge
- The impact of regulatory changes, particularly the MDR (Medical Device Regulation) shift and the increasing prioritization of FDA approval in Europe
- Navigating the evolving landscape of digital health and its intersection with artificial intelligence (AI)
- Health tech and digital health opportunities in Europe compared to the US
- A reflection on the future of healthcare innovation
- Diana and Alessio’s upcoming participation at the LSI Europe ‘23 conference in September, where they will discuss these topics in greater detail
And more!
Key moments
- 00:29 – Discussion about Panakes Partners, their first 75 million euro fund, and learnings from it.
- 05:00 – Introduction to the new strategy for fund two, focusing on medtech and adding biotech.
- 12:00 – Health tech and digital health opportunities across different European geographies.
- 27:00 – Opportunities and challenges of AI in healthcare, especially in imaging and drug discovery
- 30:23 – The spaces and technologies Diana and Alessio think are ripe for innovation.
- 35:34 – What Diana and Alessio are looking forward to discussing at LSI Europe 23 in Barcelona.
Guest links and resources:
Connect with Henry: Twitter | LinkedIn
Connect with LSI:
Browse Episodes | Twitter | LinkedIn | Facebook | Instagram
Connect with Health Podcast Network:
Browse Shows | LinkedIn | Twitter | Facebook | Instagram
